In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novo Nordisk Diagnostics Ltd.

Latest From Novo Nordisk Diagnostics Ltd.

Skye Biosciences — Advancing Nimacimab In The Anti-Obesity Market

Punit Dhillon, CEO of Skye Bioscience, tells In Vivo about the advancement of nimacimab as a weight loss mechanism within the growing space of anti-obesity therapeutics

C-Suite Speaks Metabolic Disorders
See All

Company Information

  • Industry
  • In Vitro Diagnostics
UsernamePublicRestriction

Register